- The epidemiology of hepatitis B virus infection in Korea
-
Yim SY, Kim JH
- KMID: 2457016
- Korean J Intern Med.
- 2019 Sep;34(5):945-953.
- doi: 10.3904/kjim.2019.007
The global burden of hepatitis B virus (HBV) infection is profound, and represents a public health threat as chronic infection can lead to liver cirrhosis, hepatocellular carcinoma, and death. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Performance Evaluation of the Beckman Coulter DxN VERIS Hepatitis B Virus (HBV) Assay in Comparison With the Abbott RealTime HBV Assay
-
Park J, Cho H, Choi SJ, Lee GD, Sin SH, Ryu JH, Park HS, Lee H, Kim Y, Oh EJ
- KMID: 2420276
- Ann Lab Med.
- 2019 Jan;39(1):86-90.
- doi: 10.3343/alm.2019.39.1.86
The detection and quantification of hepatitis B virus (HBV) DNA plays an important role in diagnosing and monitoring HBV infection as well as in assessing the therapeutic response. We compared... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers
-
Alzahrani , Muzaheed , Shaikh SS, Alomar AI, Acharya S, Elhadi N
- KMID: 2420275
- Ann Lab Med.
- 2019 Jan;39(1):81-85.
- doi: 10.3343/alm.2019.39.1.81
BACKGROUND: Transfusion-transmissible hepatitis B virus (HBV) infection is a major problem worldwide. Recently, confirmatory nucleic acid tests (NATs) for HBV DNA have been employed in several countries. We assessed the... -
- CITED
-
- Close
- SHARE
-
- Close
- Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis
-
Zhang ZQ, Wang YB, Lu W, Liu DP, Shi BS, Zhang XN, Huang D, Li XF, Zhou XL, Ding RR
- KMID: 2420273
- Ann Lab Med.
- 2019 Jan;39(1):67-75.
- doi: 10.3343/alm.2019.39.1.67
BACKGROUND: We examined changes in hepatitis B core-related antigen (HBcrAg) during the four sequential phases of chronic hepatitis B virus (HBV) infection: hepatitis B e antigen (HBeAg)-positive chronic infection (EPCI)... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them
-
Seo KI, Bae SH, Sung PS, Park CH, Lee HL, Kim HY, Kim HJ, Jang BH, Jang JW, Yoon SK, Choi JY, Park IY, Lee J, Lee HS, Kim SJ, Kwon JH, Chang UI, Kim CW, Jo SH, Lee Y, Tekle F, Kim JH
- KMID: 2433302
- Clin Mol Hepatol.
- 2018 Dec;24(4):374-383.
- doi: 10.3350/cmh.2017.0082
BACKGROUND/AIMS: There have been numerous efforts to reduce mother-to-child transmission (MTCT) of hepatitis B virus (HBV) with antiviral agents during pregnancy. However, there are limited data regarding the outcomes of... -
- CITED
-
- Close
- SHARE
-
- Close
- Comprehensive Laboratory Analysis of Korean Acute Alcoholic Intoxication Patients Reveals the Need for a National Hepatitis B Virus Vaccination Program in Korea
-
Shin SY
- KMID: 2426829
- Korean J Fam Med.
- 2018 Nov;39(6):360-363.
- doi: 10.4082/kjfm.17.0135
BACKGROUND: Acute alcoholic intoxication patients (AAIP) are a common public health problem. The aim of this study was to perform a comprehensive laboratory analysis for these patients to investigate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Chronic Kidney Disease and Hepatitis B Virus Surface Antigenemia
-
Lee SW, Chin HJ
- KMID: 2422091
- J Korean Med Sci.
- 2018 Oct;33(42):e274.
- doi: 10.3346/jkms.2018.33.e274
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Mouse models for hepatitis B virus research
-
Hwang JR, Park SG
- KMID: 2420820
- Lab Anim Res.
- 2018 Sep;34(3):85-91.
- doi: 10.5625/lar.2018.34.3.85
Hepatitis B virus (HBV) infection remains a major global health problem; indeed, there are 250 million carriers worldwide. The host range of HBV is narrow; therefore, few primates are susceptible... -
- CITED
-
- Close
- SHARE
-
- Close
- Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease
-
Yeo SJ, Lee HS, Jang BI, Kim ES, Jeon SW, Kim SK, Kim KO, Lee YJ, Lee HJ, Park KS, Jung YJ, Kim EY, Yang CH, Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD)
- KMID: 2417652
- Intest Res.
- 2018 Jul;16(3):400-408.
- doi: 10.5217/ir.2018.16.3.400
BACKGROUND/AIMS: This study aimed to elucidate the prevalence of hepatitis B virus (HBV) serologic markers in Korean patients newly diagnosed with, but not yet treated for inflammatory bowel disease (IBD). METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Direct Detection of Drug-Resistant Hepatitis B Virus in Serum Using a Dendron-Modified Microarray
-
Kim DH, Kang HS, Hur SS, Sim S, Ahn SH, Park YK, Park ES, Lee AR, Park S, Kwon SY, Lee JH, Kim KH
- KMID: 2411679
- Gut Liver.
- 2018 May;12(3):331-341.
- doi: 10.5009/gnl17336
BACKGROUND/AIMS: Direct sequencing is the gold standard for the detection of drug-resistance mutations in hepatitis B virus (HBV); however, this procedure is time-consuming, labor-intensive, and difficult to adapt to high-throughput... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience
-
Ahn SS, Jung SM, Song JJ, Park YB, Park JY, Lee SW
- KMID: 2407870
- Yonsei Med J.
- 2018 May;59(3):452-456.
- doi: 10.3349/ymj.2018.59.3.452
To investigate whether the use of IL-6 receptor antagonist (tocilizumab) might be associated with hepatitis B virus (HBV) reactivation in rheumatoid arthritis (RA) patients, particularly in those with resolved HBV... -
- CITED
-
- Close
- SHARE
-
- Close
- Recognition criteria for occupational cancers in relation to hepatitis B virus and hepatitis C virus in Korea
-
Kim H, Chung YK, Kim I
- KMID: 2428573
- Ann Occup Environ Med.
- 2018 ;30(1):6.
- doi: 10.1186/s40557-018-0217-0
The goal of this study was to review the scientific basis for the recognition of occupational cancer, in relation to hepatitis viral infections in Korea. Most Hepatitis B virus (HBV)... -
- CITED
-
- Close
- SHARE
-
- Close
- ELISA for Quantitative Determination of Hepatitis B Virus Surface Antigen
-
Kim SH
- KMID: 2400630
- Immune Netw.
- 2017 Dec;17(6):451-459.
- doi: 10.4110/in.2017.17.6.451
Several studies have reported a good correlation between levels of serum hepatitis B virus surface antigen (HBsAg) and covalently closed circular DNA (cccDNA) before and after antiviral therapy. As a... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibitory effects of resveratrol on hepatitis B virus X protein-induced hepatocellular carcinoma
-
Park S, Lim J, Kim JR, Cho S
- KMID: 2398500
- J Vet Sci.
- 2017 Dec;18(4):419-429.
- doi: 10.4142/jvs.2017.18.4.419
Liver cancer occurs very frequently worldwide and hepatocellular carcinoma (HCC) accounts for more than 80% of total primary liver cancer cases. In this study, the anticarcinogenic effects of resveratrol against... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of Hepatitis B Virus Infection and Psoriasis
-
Suh HY, Yoon YB, Ahn JY, Park MY, Youn JI
- KMID: 2395204
- Ann Dermatol.
- 2017 Dec;29(6):822-824.
- doi: 10.5021/ad.2017.29.6.822
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Reactivation of Hepatitis B Virus and Its Prevention in Patients with Rheumatic Diseases Receiving Immunosuppressive Therapy
-
Park EJ, Choi KS, Song BC
- KMID: 2394341
- J Rheum Dis.
- 2017 Oct;24(5):261-270.
- doi: 10.4078/jrd.2017.24.5.261
Introduction of biologic agents to treat patients with rheumatic diseases and cancer has improved clinical outcomes. However, this advance increases the risk of hepatitis B virus (HBV) reactivation in hepatitis... -
- CITED
-
- Close
- SHARE
-
- Close
- Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
-
Lee YB, Lee JH
- KMID: 2400667
- Clin Mol Hepatol.
- 2017 Sep;23(3):219-221.
- doi: 10.3350/cmh.2017.0045
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Application of CRISPR/Cas9 in Treating Hepatitis B Virus
-
Cho JY
- KMID: 2396565
- J Liver Cancer.
- 2017 Sep;17(2):111-116.
- doi: 10.17998/jlc.17.2.111
The advent of oral antiviral agents has revolutionized hepatitis B treatment. It has led to decreased incidence and mortality related to hepatocellular carcinoma. However, although nucleos(t)ide analogs (NA) are fast... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term real-world entecavir therapy in treatment-naïve hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response
-
Cho JY, Sohn W, Sinn DH, Gwak GY, Paik YH, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH
- KMID: 2387709
- Korean J Intern Med.
- 2017 Jul;32(4):636-646.
- doi: 10.3904/kjim.2016.096
BACKGROUND/AIMS: Entecavir is a potent nucleoside analogue with high efficacy and barrier for resistance. We aimed to investigate the long-term efficacy and viral resistance rate of entecavir and explore the... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Patients Undergoing Deceased Donor Liver Transplantation for Alcoholic Liver Disease Have Non-Inferior Survival Outcomes than for Hepatitis B Virus: a Real-World Experience without Minimum Abstinence before Transplantation
-
Hong SK, Yi NJ, Kim HS, Ahn SW, Yoon KC, Kim H, Lee KW, Suh KS
- KMID: 2377720
- J Korean Med Sci.
- 2017 Jun;32(6):919-925.
- doi: 10.3346/jkms.2017.32.6.919
Few studies have compared outcomes in patients undergoing liver transplantation (LT) for hepatitis B virus (HBV) and alcoholic liver disease (ALD) in Asian countries in which living donor LT (LDLT)... -
- CITED
-
- Close
- SHARE
-
- Close
